PPARG and lipodystrophy: Although data on bariatric surgery in patients with lipodystrophy are scarce, there is evidence that some individuals who underwent Roux-en-Y gastric bypass, particularly those with pathogenic variants in LMNA and PLIN1, or without variants in LMNA and PPARG (suggesting FPLD1), showed significant improvement in metabolic parameters and weight loss.